Allspring Global Investments’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
GS
SCM
VPM
VCM
WP
SL
Allspring Global Investments's RCUS Position: Q1 2026 in Review
Allspring Global Investments increased its Arcus Biosciences (RCUS) stake by 11% in Q1 2026, buying an estimated $46.8K and bringing the position to 21,041 shares worth $460K. The position accounts for ﹤0.01% of the portfolio, ranked #1412.
Allspring Global Investments first reported a position in RCUS in Q4 2021 and has held it in 18 quarters since. The position peaked at $819K in Q4 2021. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.
- Allspring Global Investments held 21,041 shares of Arcus Biosciences worth $460K as of Q1 2026.
- Allspring Global Investments bought 2,168 Arcus Biosciences shares in Q1 2026, an estimated $46.8K.
- Arcus Biosciences made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #1412 holding.
- Allspring Global Investments first reported a position in Arcus Biosciences in Q4 2021 and has held it in 18 quarters since.
- Allspring Global Investments's Arcus Biosciences position peaked at $819K in Q4 2021.
- 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.
Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.